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Summary
The human gene coding for the 70-kD polypeptide of the complement regulatory component
C4b-binding protein (C4BPa) spans over 40 kb of DNA and is composed of twelve exons. Upon
transcription in liver, or in Hep-G2 cells, this gene produces a single transcript of2,262 nucleotides,
excepting the poly A tail, that presents an unusually long 5' untranslated region (5' UTR) of
223 nucleotides . The C4BPa gene is organized as follows : the first exon codes for the first 198
nucleotides of the 5' UTR. It is separated by a large intron from the second axon including
the remaining of the 5' UTR and the coding region for the signal peptide. Each of the eight
60-amino acid repeats (short consensus repeats [SCRs]) that compose the C4BPa polypeptide
chain is encoded by a single exon, except for the second SCR, which is split in two exons. At
the 3' end of the C4BPa gene, the twelfth exon codes for the COOH-terminal 57 amino acids
of the mature protein, which have no similarities to the SCRs, and the 245 nucleotides of the
3' UTR. Examination of the nucleotide sequence of the first exon revealed an interesting
characteristic, strongly suggesting that this exon may specify a functional domain of the C4BPa
transcript . It includes two in-phase ATG codons, in a different frame respect to that coding the
C4BPa polypeptide, followed by an in-frame termination codon, also within the first exon .
Comparison between mouse and human C4BPa transcripts indicates conservation ofthis structure
within the 5' UTR. C4BP is expressed in the liver and is an acute phase protein . A computer
search of the genomic sequences upstream the transcription start site demonstrates the presence
of potential cis-acting regulatory elements similar to those found in the promoters of other liver-
expressed and/or acute phase genes.
Complement is a major defense and clearance system inthe bloodstream which can be activated by two different
routes, the classical and the alternative pathways. Activation
by each pathway leads to the formation ofcomplex enzymes,
the C3-convertases, which catalyze the crucial step of com-
plement activation, i.e., the cleavage and activation of the
complement component C3 (reviewed in reference 1) .
C4b-binding protein (C4BP)t is a regulator of comple-
ment activation . It binds to C4b, accelerates the decay of the
classical pathway C3-convertae (C4b,2a), and functions as a
cofactor in the factor 1-mediated proteolytic inactivation of
C4b (2-6) . In addition, COP binds to the anticoagulant
vitamin K-dependent protein S and renders it inactive as a
cofactor to activated protein C in the inactivation of coagu-
lation factors Va and VIIIa (7-10) .
' Abbreviations used in this paper: COP, C4b-binding protein ; DAF, decay
accelerating factor ; FXIII B, coagulation factor XIIIB subunit; H, factor
H; MCP, membrane cofactor protein; RCA, regulator of complement
activation ; SCR, short consensus repeat ; uORF, upstream open reading
frame; UTR, untranslated region .
C4BP is an abundant protein. It is present in plasma at
a concentration of 150 mg/liter (11) and, as many other com-
plement components, is probably synthesized primarily by
the liver. Recently, data from different laboratories (11, 12)
indicate that COP is an acute phase protein .
C4BP shows a characteristic molecular heterogeneity. The
major molecular form of C4BP is composed of eight chains,
seven identical 70-kD polypeptides (a chain) and one 45-kD
polypeptide ((3 chain), that are covalently linked by their
COOH-terminal regions to give the molecule a spider-like
structure (2, 13-15) . Both a and 0 chains are evolutionarily
related . They probably originated as result ofa gene duplica-
tion event and then diverged to perform different functions
(16) . The complement regulatory functions ofC4BP involve
the a chain, whereas the (3 chain appears to be the binding
site for the anticoagulant vitamin K-dependent protein S
(13, 17) .
The complete amino acid sequence of the human C4BPa
polypeptide chain has been deduced from nucleotide se-
quencing of cDNA clones (18, 19) . It belongs to a family
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ofproteins with a characteristic structural organization based
on a repetitive unit of 60 amino acids denominated as short
consensus repeat (SCR) . Because most of the proteins con-
taining SCRs bind to Cab and/or C4b, this family is referred
to as the superfamily of the C3b/C4b-binding proteins. The
typical SCR framework of conserved residues includes four
cysteines, two prolines, one tryptophan, and several other par-
tially conserved glycine and hydrophobic residues (20) . Starting
at the N1-12-terminal end, the C4BPa polypeptide chain is
composed of eight SCRs (18) . The sequence ends with a
COOH-terminal nonrepeat region containing two cysteines
that are thought to be involved in the interchain disulfide
linkage .
The human C4BPcx gene is very closely linked to that
coding for the C4BP# polypeptide (16) and probably this
is also the case in rodents (21) . In humans, the C4BPa and
C4BPO genes are arranged in tandem with the 3' end of
the C4BPa gene located 3.5-5 kb from the 5' end of the
C4BPa gene. The C4BPai and C4BPa genes have been linked
to the genes coding for the proteins membrane cofactor pro-
tein (MCP), CR1, CR2, decay accelerating factor (DAF),
factor H (H), and coagulation factor XIII B subunit (FXIII B)
(22-26) . All these proteins share the same structural organi-
zation based in the presence o£ multiple SCR units. In addi-
tion, most ofthem are complement-regulatory components .
This group ofgenes, known as the regulator of complement
activation (RCA) gene cluster (22), is located on the long
arm of human chromosome 1 (1832) (27, 28) .
The present report describes the structural organization
of the human C4BPa gene and analyzes its relationship to
other genes of the RCA gene cluster. It also provides the
structural basis for the subsequent analysis of the regulatory
elements controlling the expression of C4BPm In this re-
spect, our results demonstrate a peculiar organization of the
5' untranslated region (5' UTR) of the C4BPa mRNA which
may have important consequences in the control of the ex-
pression of this polypeptide .
Materials and Methods
Probes and Libraries.
	
The C4BPa-cDNA clone used in these
studies has been described previously (16) . It is a 2,190-by-long
cDNA clone isolated from a human liver cDNA library (HL 1001b)
purchased from Clontech Laboratories, Inc. (Palo Alto, CA) . It in-
cludes a portion of the 5' end UTR, the entire coding regions for
the signal peptide and the mature secreted protein, and the 3' UTR
with a 13 nucleotide poly A tail . It is shown in this report that
this cDNA clone only lacks the first 86 nucleotides of the 5' end
region of the C4BPot transcript . This C4BPot-cDNA clone is ap-
parently identical to that reported recently by Matsuguchi et al.
(29) . This cDNA clone, or fragments of it, was used to screen two
human genomic libraries constructed in the EMBL3 vector (HL
1006d and HL 1067j ; Clontech Laboratories, Inc.) . Additional probes
were prepared from cloned restriction fragments of the human
genomic DNA isolated from the EMBL3 clones.
Primer Extension Analysis. A 35mer oligonucleotide (GAAG-
AAAACTGCCTTGATCCTATGTAGTCCTGGTTC) corresponding
to nucleotides 19-54 ofthe noncoding strand ofthe C4BPaf-cDNA
was end labeled with T4 polynucleotide kinase to a specific ac-
tivity of -101 cpm/Rg. 10 ng of labeled primer was annealed to
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50 Wg of human liver total RNA in 50 mM PIPES buffer, pH 6.5,
containing 400mM NaCl, 1 mM EDTA, and 50% formamide over-
night at 40°C . Poly(A)* RNA and annealed primer were then
isolated using oligo-dT cellulose and precipitated in ethanol . Re-
verse transcription was carried out by adding 20 Al of50 mM TRIS-
HCI buffer, pH 8.5, containing 1 mM DTT,10 mM MgCI, 4 mM
KCI, 1 mM ofeach dNTP, 40 U ofRNasin-ribonuclease inhibitor
(Promega Corp., Madison, WI), and 10 U of AMV reverse tran-
scriptase (Promega Corp .) for 1 h at 42°C . Samples were made
0.4 M NaOH and incubated overnight at room temperature to elim-
inate RNA. After neutralization with acetic acid, samples were
precipitated in ethanol, redissolved in 6 Al of sequencing loading
buffer, and analyzed in 6% acrylamide/urea sequencing gels .
SI Nuclease Protection Assays. S1 analysis ofmRNA using single-
stranded DNA probes were performed as described (30) with slight
modifications. Briefly, single-stranded DNA probes were prepared
using T7 DNA polymerase to extend 5'-end radiolabeled oligonu-
cleotides annealed to denatured linearized-plasmid DNA templates.
Labeled probes were separated from the DNA template using 6%
acrylamide/urea sequencing gels, extracted from the acrylamide in
100 Al of 0.5 M Ammonium acetate, 1 mM EDTA, 1% SDS, and
further purified with sephadex G-50 spun columns equilibrated with
H20-
5 x 10' cpm of labeled single-stranded probe were hybridized
with 50 ug of total RNA from human liver, or with 50 Fig of
tRNA, in 20 Al of 50 mM PIPES buffer, pH 6.5, containing 400
mM NaCl, 1 mM EDTA, and 80% formamide overnight at 30°C.
After hybridization, 300 A1 of 50 mM sodium acetate buffer, pH
4.5, containing 280 mM NaCl, 4.5 mM ZnS04, 20 wg/ml salmon
sperm DNA, and 120 U of S1 nuclease (Boehringer Mannheim
GmbH, Mannheim, West Germany) was added to each sample,
and the tubes were incubated for 1 h at 30°C. Digestions were
stopped by the addition of 80 Al of 4 M ammonium acetate/20
mM EDTA and nucleic acids precipitated in ethanol . Redissolved
samples were treated overnight at room temperature with 0.4 M
NaOH to remove RNA, neutralized with acetic acid, and precipi-
tated again in ethanol . Finally, samples were redissolved in 6 P.1
of sequencing loading buffer and analyzed in 6% acrylamide/urea
sequencing gels .
DNA Sequence Analysis. Restriction fragments ofthe genomic
clones hybridizing with the C4BPa-cDNA probes were subcloned
into plasmid vectors for DNA sequencing by the dideoxy chain ter-
mination technique with either Sequenase (United States Biochem-
ical Corp., Cleveland, OH) or T7 DNA polymerase (Pharmacia
LKB Biotechnology, Uppsala, Sweden) using "S-radiolabeled
dATP. Primers for DNA sequencing were mostly oligonucleotides
derived from the C4BPtx-cDNA sequence. Programs included in
the DNASTAR software package (DNASTAR, Inc ., Madison, WI)
were used for the sequence analysis and to compare our sequences
with the National Biomedical Research Foundation (NBRF) pro-
tein sequence database and the Genebank nucleic acid database.
Results
Genomic Organization ofHuman C4B%. We have used
a 2,190-by-long human C4BPa-cDNA clone (16) to screen
two different EMBIr3 human genomic libraries . Several over-
lapping clones hybridizing to this probe were identified, span-
ning a region of -60 kb. Five of these clones, G562, G211,
G912, G105-2, and G17, were selected and characterized by
restriction endonuclease digestion and Southern blot hybrid-
ization with different C4BPcx-cDNA-derived probes. The
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Figure 1. Map of the human C4BPa gene. The first line represents the complete EcoR I (R), BamH I (B), Hind III (M, and Sal I (S) restriction
map of the C4BPct gene. It resulted from the alignment ofthe restriction maps of five selected overlapping genomic clones, G562, G211, G912, G105-2,
and G17. The position of these clones is indicated below the map. The localization of the twelve exons that compose C4BPa is shown with vertical
bars labeled from 1 to 12 . The black solid circle (") is to indicate the position of the 3' end of the C4BPfl gene .
Figure 2. Exon/intron organization of the C4BPct gene . (a) The precise size of each of the C4BPa exons and the sequences corresponding to their
3' and 5' exon/intron boundaries are shown. Sizes ofthe introns, excepting intron 5 are approximate and were determined by agarose gel electrophoresis .
(b) Diagramatic representation of the genomic organization of the C4BPa transcript. Solid bars (-)are to indicate sequences of the mRNA corre-
sponding to the 5' and 3' untranslated regions (UT) . Coding regions are boxed. The signal peptide is referred to as L and the 57 amino acid COOH-
terminal region as CT
alignment of these genomic clones is presented in Fig. 1 to
show the overall organization of the human C4BPa gene .
C4BPa is composed of 12 exons spanning 40 kb of DNA.
The precise size of each of these 12 exons and the results
of the analysis of all exon/intron junctions are described in
Fig. 2 . The data were obtained by comparison of the C4BPa-
cDNA sequence to those sequences obtained from selected
genomic subclones . Fig. 2 also presents a description of the
structural domains associated with each of the exons and es-
timates ofthe length of the different introns based on agarose
gel electrophoresis analyses. These results fully confirm and
extend preliminary data on the organization of the human
C4BPa gene (31, 32) .
The 5' UTR ofthe C4BPa transcript is split in two exons .
The first exon includes the initial 198 nucleotides of the 5'
UTR (see below) and it is separated by a -9-kb-long inter-
vening sequence from the second exon (167 bp), coding for
the remainder of the 5' UTR and the predicted coding re-
gion for the signal peptide. The third exon codes for the first
of the SCRs and starts the coding region for the mature
secreted protein . Each of the eight SCRs that compose the
C4BPa polypeptide chain is encoded by a single exon, ex-
cept for the second SCR, which is split in two exons. Fi-
nally, the twelfth exon of the C4BPa gene codes for the
COOH-terminal 57-amino acid region, which has no similar-
ities to the SCRs, and the 245 nucleotides o£ the 3' UTR
(Fig. 2) . Characterization of the precise position to which
the poly A is added could not be determined since the first
six A nucleotides ofthe poly A tail found in the cDNA clones
are also present in genomic DNA.
A partial structure for the gene coding the murine homo-
logue to human C4BPa has been reported (33) . It include,
six exons that are homologous to the fifth, sixth, seventh,
tenth, eleventh, and twelfth exons of human C4BPa. The
human and murine C4BPa transcripts, as will be shown in
the Discussion, present very similar 5' UTRs. Thus, excepting
for the absence ofexons 8 and 9, the organization ofthe mu-
rine C4BPa gene can be anticipated to be similar to that of
the human C4BPa gene.
It should be mentioned that the screening of the human
genomic libraries with the C4BPa-cDNA-derived probes also
yield a separated set of overlapping clones with exon-like
regions 80% homologous to the C4BPa exons. Pulsed field
gel electrophoresis analyses of human genomic DNA, using
specific probes, demonstrated that the two sets of C4BPci-
specific overlapping clones map to very closely linked, but
distinct, genomic regions (16) . Thus, the second set ofgenomic
clones probably identifies a "recent" duplication of the C4BPa
gene, referred to as C4BPa-like gene, which will be described
elsewhere (P. Sanchez-Corral, F. Pardo-Manuel, and S .
Rodriguez de Cordoba, manuscript in preparation) .
Characterization of the Transcriptional Unit of the Human
C4BPa Gene.
	
The 2,190-by-long cDNA-C4BPa clone is
the one among several cDNA clones that contains the lon-
gest sequence upstream the putative translational start site
for the C4BPa polypeptide. Genomic sequences upstream
the cDNA start site were obtained by DNA sequencing the
G562RV0.3 subclone, a 352-by-long EcoR I/EcoR V re-
striction fragment of the phage clone G562 including the
first 98 by of the C4BPa-cDNA, but no canonical TATA
or CAAT boxes were encountered that could help to localize
the cap site of the C4BPa-mRNA.
To characterize the transcription start site of the human
C4BPa gene and to rule out the possibility ofadditional exons,
we used a combination ofprimer extension and S1 nuclease
protection assays (Fig. 3) . A 31 P-labeled 35mer oligonucleo-
tide, corresponding to nucleotides 19-54 of the noncoding
strand ofthe C4BPa-cDNA was annealed to total RNA from
human liver, or from the human hepatoma cell line Hep-G2,
and extended with AMV reverse transcriptase . As shown in
Fig. 3 a the antisense 35mer oligonucleotide extended up to
a single labeled fragment of 139 nucleotides, which suggests
that the mRNA start site is located 104 nucleotides upstream
the 3' end of the primer. Identical results were obtained using
RNA from the human hepatoma cell line Hep-G2 (data not
shown) .
The same 35mer oligonucleotide was also used to generate
a 333-by-long single-stranded DNA probe using the
G562RV0.3 restriction fragment as the template (Fig . 3 c) .
In agreement with the results of the primer extension ex-
periments, the S1 nuclease protection assays of this probe with
total liver RNA showed a major "protected" band of nearly
identical size to that found by primer extension analysis (Fig.
3 b) . This finding further supports that the C4BPa gene tran-
scription is initiated at a single site located 86 nucleotides
upstream the 5' most proximal nucleotide found in our lon-
gest C4BPa-cDNA clone. Taking into account these 86
nucleotides, the predicted length of the entire C4BPa tran-
script, excepting the poly A tail, is estimated in 2,262 nucleo-
tides .
Close examination of the 5' UTR sequence (198 bp) in-
cluded within the first exon revealed the presence, in a different
frame with respect to that encoding the C4BPa polypep-
tide, of two in-phase ATG codons at positions 25 and 82,
which potentially could initiate translation of a small "up-
stream open reading frame" (uORF) . This unexpected finding
together with the unusual genomic organization of the 5'
UTR of the human C4BPa-cDNA prompted us to confirm
Figure 3 . Mapping of the transcription start site of C4BPa by primer extension and Sl nuclease protection assays. (a) A 32P-labeled 35mer oligonu-
cleotide, corresponding to nucleotides 19-54 ofthe noncoding strand ofthe C4BPo-cDNA, was annealed to total liver RNA to prime reverse transcrip-
tion as described under Materials and Methods. The arrow shows the extended fragment of 139 nucleotides resulting from this experiment. (b) The
35mer oligonucleotide was also used in the generation of a 333-nucleotide-long single-stranded DNA probe for the Sl nuclease protection assays (see
3 c) . This probe was annealed to 50 ug of total liver RNA, or 50 ug of tRNA, and digested with Sl nuclease (see Materials and Methods) . The
arrow shows the protected fragment of-139 nucleotides. Minor bands below this fragment are probably consequence ofS1 sensitive sites due to strong
secondary structure in this region of the transcript . (c) Diagramatic representation of the positions of the 35mer, thecDNA start site and the transcription
start site. In all the experiments the 35mer ohgonucleotide was used to generate a sequence ladder from clone G562RV0.3, which was used as a size reference.
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Figure 4.
	
S1 nuclease analysis to identify potential alternative spliced
C4BPa transcripts. S1 nuclease protection assays were performed as de-
scribed under Materials and Methods, using a 324-nucleotide-long single-
stranded DNA input probe spanning over sequences encoded by the first,
second, and third exons. This probe, outlined in the left side of the figure,
also includes an unrelated 54 nucleotide 3' extension indicated as a zigzag
line. Position of the splice junctions between exon I and II, and between
exons II and III, are indicated by arrows . S1 nuclease protection using 50
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that the 2,262-by-long transcript, including both the first
and second exons, identifies the majority of the C4BPci-
mRNA in liver.
Total RNA from human liver was used this time to pro-
tect a 324-nucleotide-long 5'-end 31P-labeled single-stranded
DNA fragment including 270 nucleotides corresponding to
the sequence from position 145 to position 415 of the non-
coding strand of the C4BPot-mRNA ; i .e ., spanning the last
54 by of exon I, exon II, and the first 49 by of exon III .
As shown in Figure 4, a "protected" band was detected that
exactly corresponds to the length of the C4BPa-mRNA se-
quence included in the input probe . More important, no ad-
ditional bands were observed (particularly in the vicinity of
the boundaries between the third and second exons or be-
tween the second and the first exons), thus indicating that
most, it not all, C4BPa transcripts in liver include the same
223-by-long 5' UTR preceding the first ATG in-frame with
the coding sequence for C4BPcx
Genomic Sequences Upstream the Transcription Initiation Site.
Over 5 kb of genomic DNA flanking the Tend ofthe C4BPci
gene were sequenced using various subclones of the G562
A genomic clone. As a first result, the analysis ofthis genomic
sequence demonstrates that the 3' end of the C4BPQ gene,
which we have previously shown to lie adjacent to the 5' end
of the C4BPoi gene (16), is exactly located 4,178 by from
the transcription start site of the C4BPot gene.
COP is expressed in the liver and is an acute phase pro-
tein (12, 13) . Analysis of the 4,178-bp nucleotide sequence
separating both genes demonstrates the presence of several
sequences that share identity with the consensus sequence
(TT/GNNGNAAT/G) recognized by NF-IL6, a nuclear factor
implicated in the gene regulation of acute-phase genes (34) .
Some of these elements and their positions are shown in Fig.
5 . Although no data on functional assays for these potential
regulatory elements areyet available, it is suspected that some
ofthem could be responsible for the observed enhanced secre-
tion of C4BP by Hep-G2 cells upon stimulation by IIT6 (13) .
The human C4BPci gene does not present a conventional
TATA promoter. However, a search of this sequence to iden-
tify potential cis-acting regulatory elements demonstrated the
presence of the motif GTTAATCATTCAT at position -50
(Fig. 5) . This 13-bp sequence matches the proposed consensus
sequence for the binding site of HNF1 in the promoter re-
gion of other liver-expressed genes (35) .
Discussion
The C4BPcx polypeptide belongs to a family of proteins
characterized by a structural organization based on the pres-
ence of internal repeat units of 60 amino acids (SCR) that
share a framework of highly conserved residues (20) . Human
C4BPci is composed of eight of these repeats followed by
a 57-amino acid nonrepeat region (18) .
wg of total liver RNA results in a single protected fragment of270 nucleo-
tides. The same oligonucleotide utilized in the preparation of the single
stranded DNA probe was used to generate the sequence ladder that was
included in the sequencing gels as a size reference for these experiments.
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-191
tctggcttcaaattcaaattacctttccacttaggggaaatggttggcaga
-81
ggagaaaataaacgattgcgacatgttacgaagaatgaggactagcaaagaggaaggagc
ttaggtaaacagtgctgctttatttctgctg ttaatcattcat tgggcccgtcaaaagtt
40
,-. mRNA star site I
tctgcccatctatttccatcAACCGTCCTTGACCAGCCAACCACATGGCTGAAATTCAGG
100
t I
GACTCTTTGGTGGAGCAATTACCAGTCAACTTCAGGGTATTATGATAAACTGTGATGTGG
160
I
GGAGGAACCAGGACTACATAGATCAAGGCAGTTTTCTTCTTTGAGAAACTATCCCAGATA
210
TCATCATAGAGTCTTCTGCTCTTCCTCAACTACCAAAGgtcggtggacta
Figure 5 . Sequences flanking the transcription start site . Upper case
letters indicate the nucleotide sequence included within the first exon . The
sequences -118 to -126 (TGTCGCAAT), +51 to +59 (TGGAGCAAT),
and +189 to +181(TTGAGGAAG) match the consensus for the binding
site of NF-IL6 (TT/GNNGNAAT/G) (34) . The sequence -50 to -38
(GTTAATCATTCAT) matches the consensus for the binding site ofHNF1
(GTTAATNATTNAC/T) (35) . These sequences are underlined in the
figure. The two upstream ATG codons and their termination codon are
double underlined. The asterisk shows the 5' most terminal nucleotide
found in cDNA clones.
We present here the complete genomic organization and
the structure of the transcriptional unit of the human gene
coding for the a chain of the COP molecule . The C4BPa
gene spans over 40 kb ofDNA and comprises 12 exons . The
organization of the C4BPa gene matches a general pattern
found in other RCA genes like MCP, CR2, CR1, CRl-like,
DAF, and H, for the location ofmost of the splicejunctions
(36-40) . The similarities observed between C4BPa and other
RCA genes canbe summarized as follows: (a) C4BPa presents
identical genomic arrangement for the boundary between the
signal peptide and the mature polypeptide to that found in
the CR1, CR2, and DAF genes (36, 39, 41) . In these four
genes the exon coding for the first, NH2-terminal, SCR in-
cludes the last two base pairs of the codon for the Gly res-
idue predicted to be the site for the cleavage of the signal
peptide; (b) most of the SCRs that compose C4BPa are en-
coded by single exons and, like in other RCA genes, all the
splice junctions between the SCR-coding exons occur after
the first base ofa codon; and (c) all RCA genes characterized
thus far include at least one SCR split in two exons. C4BPa
is not an exception to this rule and the second SCR is en-
coded by exons 4 and 5 . In addition, the splice dividing the
second SCR of C4BPa occurs at identical position as in those
other RCA genes (Fig. 2) .
In contrast with the similarities found between the genomic
organization of the SCR-coding regions, C4BPa is clearly
different from the other RCA genes in the non-SCR regions .
Thus, in addition to the reported characteristic 000H-
terminal region of the C4BPa polypeptide (18), the C4BPa
gene presents a distinct 5' end organization including a first
exon coding exclusively for 5' UTR sequences (see below) .
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The results of the comparison between the genomic orga-
nization of the C4BPa gene with other RCA genes are in
agreement with the current understanding of the evolution
of the RCA gene cluster. Genes encoded at this location most
likely originated as a result of the duplication of an ancient
gene organized by SCRs and then diverged to present dis-
tinct COOH-terminal coding regions as well as different
5'-noncoding regions . These genes maintained, however, the
characteristic genetic organization of the SCR exons and it
can be speculated that this fact facilitated the appearance of
the successive generations of RCA genes . The peculiar unifor-
mity of the splice junctions in this region, which permits
insertion or deletion ofSCRcoding exons without changing
the correct reading frame, provides a particularly suitable struc-
tural organization for the evolution of these genes involving
genetic mechanisms, like unequal recombination, which are
normally deleterious for a gene without this feature. This
model for the evolution of the RCA genes is supported by
their physical localization within the RCA gene cluster. Thus,
RCA genes presenting similar "non-SCR regions" map to-
gether within specific subregions ofthe RCA gene cluster (16).
The C4BPa gene shows a peculiar 5' end organization.
It presents an unusually long 5' UTR that is encoded by two
exons separated by a large N9-kb intron. The first exon codes
for the initial 198 nucleotides of the 5' UTR of the C4BPa-
mRNA and includes two ATG codons that lie in a sequence
context suitable for being the translational start site ofa small
uORF. With the exception ofthe proto-oncogene transcrip-
tional units, in which >65% of them include ATG codons
5' to the authentic translation start site, uORFs are relatively
rare in vertebrate mRNAs (42) . The existence of uORFs in
the 5' UTR of the C4BPa gene is particularly interesting
since uORFs have been shown to influence the translational
efficiency of the mRNAs (43-45) .
The complete amino acid sequence of the murine homo-
logue of human C4BPa has been deduced from nucleotide
sequencing of a 1,889-by-long cDNA clone isolated from a
mouse-liver-cDNA library using human C4BPa-cDNA
probes (46) . The predicted mouse C4BPa polypeptide chain
is 51% identical at the amino acid level to its human homo-
logue and lacks the residues corresponding to the fifth and
sixth SCRs ofhuman C4BPa. Upstream from the predicted
codon starting the coding region for the mature secreted pro-
tein, the murine cDNA clone includes 370 by with two in-
phase ATG codons, positions 203 and 332, which yield puta-
tive signal peptides of 56 and 13 residues, respectively (46) .
Prompted by the peculiarities found in the 5' end region of
the human C4BPa transcript, we have reexamined the 5' end
region sequence of this 1,880-by-long murine C4BPa-cDNA
clone and found that further upstream of the two ATG codons
in-phase with the C4BPa polypeptide there are three addi-
tional ATG codons, two ofwhich (positions 32 and 107) could
be translation start sites for two small uORFs. These uORFs
lie within a region of this clone that was earlier suggested
to correspond to the 3' end of an intron sequence (46) . Align-
ment of the murine cDNAC4BPa sequence and the com-
pleted human C4BPa sequence, however, shows homology
between both 5' UTRs (data not shown), strongly suggesting
that the sequence including the two uORFs belongs to the
murine C4BPa mRNA and supporting the view that the
1,889-by-long cDNA clone reported in reference 46 represents
the entire sequence of the murine C4BPa transcript .
To identify unusually conserved sequences between human
and mouse C4BPct in the region upstream from the predicted
codon corresponding to the NH2 terminus of the mature
secreted protein, we have performed dot matrix comparisons
at the nucleotide level using high stringent conditions (window
= 20 n; identity = 80%). This analysis demonstrates the
existence of two of such conserved regions (Fig . 6 a) . One
of these regions corresponds to that containing the uORFs
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Figure6 . Comparison of the human
and mouse C4BPa transcripts . (a) Dot
matrix comparison of the human and
mouse (46) nucleotide sequences up-
stream the codnn for the NH2-termi-
nal amino acid residue of the mature
secreted C4BPa polypeptides . Param-
eters were set for a window of20 nucle-
otides and 80% identity. (6) Alignment
of thehuman andmousetranscriptional
units. Hatched boxes (®) identify the
uORFs, dotted boxes (p) the coding
regions for the signal peptide, and solid
boxes (0) the regions coding for the
mature secreted polypeptides .
and the other includes the coding sequences for the signal
peptide.
Close examination of the nucleotide sequences surrounding
the T-most proximal ATG codons starting either the upstream
or the signal peptide coding frames indicates, however, that
these ATG codons have not been conserved ; i.e., human and
mouse C4BPa present these ATG codons at distinct sequence
positions . Interestingly, when we compared the deduced
human and mouse amino acid sequences encoded at these
locations, we found that, in spite of using different ATG
codons, the reading frames have been maintained . Alignment
of the deduced sequences for the signal peptide, assuming
that the translation start site is located at the most 5'-proximal
in-phase ATG codon, is shown in Fig. 6 b . Except for nine
extra residues at the beginning of the murine sequence, both
signal peptides were 56% identical . In addition, they share
other positions with chemically similar residues . These results
strongly argue in favor of the ATG positions 203 and 224,
mouse and human, respectively, as the authentic translation
start sites of the C4BPci polypeptides .
The comparison of the deduced amino acid sequences of
the u0RFs present in the 5' UTR of the human and mouse
C4BPci shows a degree of conservation between these se-
quences comparable to that found between those coding for
the signal peptides (Fig 6 b) or between those coding for the
mature secreted protein (46) . The striking conservation of
these 5' UTRs sequences between human and mouse C4BPa
suggests a functional role for these uORFs. Experiments are
in progress to test this hypothesis by investigating a possible
role of these sequences in controlling the expression of the
C4BPot polypeptide.
C4BP is unique among RCA proteins in that it is orga-
nized by two functionally distinct polypeptide chains (C4BPcx
and Mpg). They share similar C001-1-terminal regions
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